Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 4Phase 3 2Phase 1/2 2

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 3

Conditions

Keratosis, Actinic 2Skin Diseases 1Connective Tissue Diseases 1Carcinoma, Basal Cell 1Bowen's Disease 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × OTHER × methyl 5-aminolevulinate × Clear all
NCT03909646 2025-05-06

BOWTIE

Maastricht University Medical Center

Phase 4 Completed
250 enrolled

Bowen's Disease

NCT02464709 2019-08-28

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Joint Authority for Päijät-Häme Social and Health Care

Phase 4 Completed
72 enrolled
Dermatologic

Keratosis, Actinic

NCT01538901 2017-09-12

AKtransplant

Medical University of Vienna

Phase 4 Terminated
10 enrolled
Dermatologic

Keratosis, Actinic

NCT01491711 2014-01-31

Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate

Maastricht University Medical Center

Phase 4 Unknown
162 enrolled
Dermatologic

Carcinoma, Basal Cell, Connective Tissue Diseases, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡